Ascendis Pharma A/S Ordinary Share trailing returns
Ascendis Pharma A/S Ordinary Share's 10-year return is +27.5% a year (CAGR) (+1033.7% cumulative). How Ascendis Pharma A/S Ordinary Share (ASND) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +0.2% | |
| 5 days | — | +1.0% | |
| 1 month | — | -14.8% | |
| YTD | — | +6.9% | |
| 1 year | +13.4% | +13.4% | |
| 5 years | +7.0% | +40.4% | |
| 10 years | +27.5% | +1033.7% | |
| Since inception (2015) | +23.8% | +1110.1% |
Growth of ASND
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from ASND's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Ascendis Pharma A/S Ordinary Share's 10-year return?
- Over the last 10 years, Ascendis Pharma A/S Ordinary Share (ASND) returned about +27.5% a year annualized (+1033.7% cumulative total return).
- What is Ascendis Pharma A/S Ordinary Share's return since inception?
- Since 2015, Ascendis Pharma A/S Ordinary Share (ASND) has compounded at about +23.8% a year — +1110.1% in total.